FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Info Collection on Device Fees for Small Businesses

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension on a guidance for Medical Device User Fee Small...

Global Biotech Development Surge Continues: Tufts Study

[ Price : $8.95]

A Tufts Center for the Study of Drug Development analysis says the global biotech product development surge that started in the 19...

Prostate Cancer Trial Endpoint Guidance

[ Price : $8.95]

FDA issues a draft guidance on considerations for using a metastasis-free survival endpoint in some prostate cancer drug trials.

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that include StemGenex Biologic Laboratories and U.S. Vascular.

FDA Accepts Shire sNDA for Pediatric Short Bowel Syndrome

[ Price : $8.95]

FDA accepts for review a Shire supplemental NDA to expand the indication of Gattex (teduglutide [rDNA origin]) for injection to pe...

Info Collection on IND Sponsor Surveys

[ Price : $8.95]

Federal Register notice: FDA submits to OMB a new information collection entitled Surveys and Interviews With Investigational New ...

510(k) Substantial Equivalence Guidance Explained

[ Price : $8.95]

CDRH biomedical enginer Ifeanyi Uwemedimo explains provisions in a newly-finalized guidance on benefit-risk assessments for 510(k)...

FDA Wants More Informed Consent Flexibility

[ Price : $8.95]

FDA says it wants to give institutional review boards some greater flexibility to waive or alter informed consent requirements und...

Listing of Information Collections Approved by OMB

[ Price : $8.95]

Federal Register notice: FDA publishes a list of information collections that have been approved by OMB.

Meeting on Drug Development Tool Process

[ Price : $8.95]

Federal Register notice: FDA announces a 12/11 public meeting entitled Drug Development Tool Process under the 21st Century Cures ...